To compare the performance of depressed patients to healthy control subjects on discrete cognitive domains derived from factor analysis and to examine the factors that may influence the performance of depressed patients on cognitive domains in a large sample.
M DD is associated with a range of cognitive deficits. Attention, memory, speed of processing, verbal fluency, and executive function have been examined and while some studies report impairment in these domains, [1] [2] [3] [4] [5] others have not found differences in patients, compared with control subjects. 6, 7 The factors that may contribute to cognitive dysfunction in MDD have not been systematically examined in large samples. Some, 8, 9 but not all, studies 3 report that age is negatively associated with verbal memory and executive function. Severity of mood symptoms negatively correlated with processing speed 10 and executive function 11 in some studies, but not with verbal memory in other studies. 2, 12 The number of past depressive episodes predicted performance on recollection memory, 13 recall memory, 14 and executive dysfunction 1 ; but not all studies report the same association. 15, 16 Age of onset of illness 6 (Bearden et al 2 ), duration of illness [17] [18] [19] ( Reischies and Neu 15 and Verdoux and Liraud 20 ) , and number of hospitalizations 16, 17 predicted poor performance on one or more cognitive domains. Medication use did not affect cognitive performance in some studies, 15, 21 but other studies have reported superior performance for treated patients. 19, 22 Given the heterogeneity in study results examining the factors contributing to cognitive performance in MDD, we decided to systematically examine an array of clinical and demographic variables in a large sample of patients to determine which factors are reliably associated with performance in patients with MDD. We employed measures for verbal and visual memory, speed of processing, verbal fluency, and executive functions.
Methods

Participants
Depressed patients (aged 15 to 75 years) were recruited from the Mood Disorder Clinic, St Joseph's Healthcare, Hamilton, between September 1999 and March 2006 . Patients (n = 149) with MDD diagnosed by a treating psychiatrist, and confirmed by SCID, 23 clinical follow-up, and chart review, were enrolled in the study. Recruitment of 104 control subjects (aged 15 to 75 years) for comparison with the patient population was facilitated by the staff, local advertisement, and within the local community. Patients were excluded if their mother tongue was not English and (or) they had psychotic symptoms, past history of head injury, neurological disorder, or electroconvulsive therapy or transcranial magnetic stimulation within the last 6 months. Control subjects were excluded if their mother tongue was not English, if they had a current or lifetime history of psychiatric or neurological disorder, or history of drug or alcohol dependence as determined by interview. Approval of the local research ethics board at St Joseph's Healthcare, Hamilton, was obtained and all participants signed informed consent prior to participation. The study was conducted in accordance with the Tri-Council of Canada.
Outcome Measures
Assessment of demographic variables for patients and control subjects included the National Adult Reading Test, 24 which is a valid estimate for the premorbid FSIQ, 25 and the HDRS, 26 which remains the gold standard for measuring severity of depressive symptoms. 27, 28 Patients were asked about age of onset of illness, duration of illness, duration of medication, number of hospitalizations, number of depressive episodes, history of drug or alcohol abuse, history of anxiety, and family history of mood disorder. The information given by the patients were independently verified by checking the consultation notes and reviewing their clinical charts in addition to reviewing the SCID. This was followed by neuropsychological assessment, which included the following measures: the CVLT 29 (a measure for verbal recall, learning, and recognition memory); the CVMT 30 (a design recognition test to assess visual memory); the TMT-A and TMT-B 31 (a paper and pencil timed test of visuomotor speed, with TMT-B also being a test of executive function); the DSST 32 (a test of coding with the first part measures visuomotor speed and working memory, while the second part measures visual recall); the SILS 33 (the abstraction subtest assesses abstract concept formation and verbal intelligence); the COWAT 34 ( a measure of verbal fluency); and the Computerized Process-Dissociation Task 35 (a test for recollection and habit memory). Twenty dependent variables (subtests) were identified from the neuropsychological measures ( Table 1 provides a list of variables).
Statistical Analyses
Demographic variables for patients and control subjects were compared using independent sample t tests for continuous variables and chi-square statistics for categorical variables (a < 0.05, 2-tailed). Exploratory between-group ANCOVA (depressed group, compared with control group as independent between-group variable) was performed to examine the effect of demographic variables included as covariates (that were significantly different between the 2 groups: education and HDRS) in the model on all of the dependent variables extracted from the neuropsychological measures.
A principal components factor analysis using Equamax rotation and Kaiser normalization was performed to grouprelated dependent neuropsychological variables into meaningful cognitive constructs. Data for all patients and control subjects (n = 253) were included to increase the number of subjects and improve the accuracy of loading of factors. We did not determine a priori the number of factors to explore the underlying structure of the dependent neuropsychological variables that were included in the analysis. The grouping of the dependent variables into components later facilitated the grouping of variables for the following multivariate MANCOVA and regression analyses.
Cognitive performance of patients was compared with control subjects using MANCOVA models (patients, compared with control subjects as an independent between-group variable and related subtests of neuropsychological measures that loaded on the same component in the factor analysis as the dependent variables included in separate MANCOVA models) to control for the differences in potentially confounding demographic variables and to protect against multiple tests (that is, to reduce the probability of type II error while protecting against type I error). Education and (or) HDRS were included as covariates in the model when they were shown to have a significant effect on one or more dependent neuropsychological variables included in the MANCOVA model (as determined by the prior exploratory ANCOVA).
Finally, z scores of the dependent neuropsychological variables that loaded on the same component in the factor analysis were used to create composite scores representing cognitive constructs for the patients (n = 149). Variables that are reverse-scaled such as the TMT-A and TMT-B subtests were taken into consideration when creating the composite scores. The correlations between the composite scores and the suggested predictor variables were examined using Pearson correlation analysis, while the unique contribution of the predictor variables to the patients' performance was examined using multivariate regression analysis. We used the z scores and not the factor scores as dependent variables in the regression analyses because of the suggested differences in the statistical assumptions of measurement error between the factor analysis and regression analysis. 36 We examined the contribution of the following demographic and clinical predictor variables in regression analyses using the composite cognitive scores as our dependent variables: age, education, FSIQ, history of drug abuse, history of alcohol abuse, first-degree family history of mood disorder, severity of depression at the time of assessment, age of onset of illness, duration of illness, number of depressive episodes, number of hospitalizations, duration of medication (duration since subjects started medication for MDD for the first time in his or her life), and the presence or absence of anxiety. All analyses were conducted using SPSS software, version 13.0 (SSPS Inc, Chicago, IL).
Results
Baseline Demographics
There were no significant differences between depressed patients and healthy control subjects on age, sex, or FSIQ. The groups differed on HDRS and on years of education (control subjects had a higher mean education; Table 2 shows descriptive statistics and between-group effects). Twenty-four percent of the depressed patients were euthymic (HDRS ³ 8) and 15% had at least moderate severity (HDRS ³ 20). eFigure 1 is available online. 
Exploratory ANCOVA
Education had a significant main effect in the exploratory ANCOVA on one or more of the verbal memory, speed of processing, verbal fluency, and executive function variables, and therefore was included as a covariate in the corresponding MANCOVA models. HDRS had a significant main effect only on the speed of processing and therefore was included as a covariate in the corresponding MANCOVA model.
Factor Analysis
The factor analysis confirmed that 18 of the 20 neuropsychological variables could be grouped into a 5factor solution with an eigenvalue of greater than 1, individual variable loading of greater than 0.5, explaining 67% of the total variance. All CVLT variables except list B loaded on the same component, which was labelled verbal memory and explained 27% of the variance in the total sample. TMT-A, TMT-B, and DSST loaded on the second component, which was labelled speed of processing and explained 12.2% of the variance in the total sample. The SILS, COWAT, and habit memory loaded on the third component, which was labelled verbal fluency and explained 11.1% of the total variance. The DSSTr and CVMT loaded on the same component visual memory and explained 9.4% of the total variance. TMT-A error (TMT-Ae) and TMT-B error (TMT-Be) loaded on an executive function component and explained 7.4% of the total variance (loading of factors are shown in Table 3 ). Two variables did not load on any of the components; although they are of interest, they were excluded from further analyses; these were the interference list B (immediate free recall) on the CVLT and the Process-Dissociation Task recollection (recollection).
MANCOVA
We computed 5 MANCOVA models; each included related neuropsychological variables extracted from the factor analysis. The model representing verbal memory showed that depressed patients perform significantly lower than control subjects (F = 2.0, df = 1,243, P = 0.05; controlling for education). The model showed medium effect size for the difference (h 2 = 0.06, power = 0.8). The second model representing speed of processing was also significant (F = 5.7, df = 1,188, P = 0.001; controlling for education and HDRS). The model showed medium effect size for the difference (h 2 = 0.08, power = 0.95). The visual memory model showed a trend (F = 2.5, df = 1,133, P = 0.08; no covariate was used). Neither executive function nor verbal fluency models were significant (F = 1.4, df = 1,189, P = 0.24; F = 0.48, df = 1,142, P = 0.62, respectively; controlling for education in both models). Table 4 shows the exploratory ANCOVA effects of education and HDRS, and the MANCOVA between-group effects.
Regression Analyses
Composite scores representing verbal memory and speed of processing constructs were used as the dependent variables in the regression models. Each of the 2 composite scores was first tested for correlation with the clinical and demographic factors identified as possible predictors for cognitive performance in patients ( Table 5 shows the results of correlations). The correlations were followed by a backward stepwise regression analysis to examine the independent contribution and degree of overlap between the predictor factors on both cognitive constructs. Only the factors that were significantly correlated with the composite scores were included in the regression models. Missing values were dealt with by listwise deletion. The verbal memory composite score was significantly correlated with education, estimated FSIQ, history of drug abuse, number of episodes, and duration of illness. The backward stepwise regression model was significant (F = 5.5, df = 5,129, P < 0.001, adjusted R 2 = 0.14) but only the estimated FSIQ and the duration of depressive illness were significant contributors to verbal memory performance in depressed patients (b = 0.25, P = 0.006 and b = -0.26, P = 0.008, respectively). The second regression model was computed to examine predictors of performance on speed of processing. Age, number of episodes, duration of illness, duration of medication, and number of hospitalizations were significantly correlated with speed of processing composite score and were subsequently examined as predictor variables for performance of patients. The backward stepwise regression model was significant F = 13.3, df = 3,33, P < 0.001, adjusted R 2 = 0.51, but only the duration of illness and number of hospitalizations were significant predictors for speed of processing in depressed patients after elimination of number of episodes and duration of medication (b = -0.37, P = 0.02; b = -0.28, P = 0.04, respectively).
Discussion
Cognitive Performance in Patients, Compared With Control Subjects
Our study compared the cognitive performance of patients with MDD to healthy comparison subjects, and examined the factors that contribute to performance of patients on measures of verbal memory and processing speed. Patients performed at lower levels than control subjects on verbal short delayed free recall, the free and cued long delayed recall, learning, and recognition memory, and on the speed of processing variable of the DSST. Performance of patients and control subjects was equivalent on immediate verbal recall, visual recall, verbal fluency, and executive function.
The deficits experienced by depressed patients in our sample are therefore largely confined to the domains of verbal memory and speed of processing. Our findings are consistent with several studies that note the presence of verbal memory deficits in depressed patients, compared with healthy control subjects (in free recall 2, 37, 38 ; cued recall 37 and recognition 2 ). However, other studies have reported no difference on free and cued recall and recognition memory measures. 7, 39, 40 Besides the disparity in the measures employed to assess verbal memory in depressed patients, several factors contribute to the discrepancies in the results of studies, including the differences in the characteristics of the patients assessed. As an example, studies that used the Luria Verbal Learning Test or the Hopkins Verbal Learning Test reported no impairment in immediate or delayed recall. 3, 41 A study 42 that used younger (mean age 21 years), less depressed (mean HDRS 2.5), and mostly medicated patients, reported impaired free recall but not cued recall or recognition memory. Moreover, disease-related factors such as number and duration of episodes are not consistently reported among studies. Studies often identify a few factors while excluding other factors that may contribute to the observed pattern of results. Further, the choice of the statistical methods employed in the analysis influences the results; studies that include several dependent variables in the same model to control for type I error have a lower probability of detecting verbal memory impairment in patients compared with control subjects. 7 Studies have frequently employed small sample sizes, which make it difficult to interpret the meaning of negative results. In our analysis we employed a relatively large sample of depressed patients and healthy control subjects and were able to detect effect sizes in the moderate range for verbal memory.
In contrast to verbal memory, no difference was observed between depressed patients and control subjects in visual memory in our sample, a finding that is consistent with previous studies. 41, 43 However, studies 3,44 that used the Wechsler Visual Memory subscale detected impairment in visual memory in depressed patients. Another study 12 reported significant visual memory impairment that was lost after Bonferroni correction for multiple tests. Patients in our sample also showed dysfunction on the DSST similar to that reported by some studies. 3, 45, 46 Others did not find differences in patients compared with control subjects; the discrepancy may be explained in part by the clinical characteristics of the patients enrolled in these studies. Studies 4,41 that compared nonmedicated depressed patients with healthy control subjects did not find impairment in DSST. Results of the letter fluency assessment in our sample showed that both depressed patients and healthy control subjects were equivalent, which is in agreement with most studies. 9, 16, 37, 47 Studies 4,48 that included patients with more depressive symptoms (HDRS > 20) in addition to higher proportion of hospitalized patients reported poor performance in depressed patients, compared with control subjects.
We found that executive function as measured by the error component of the TMT-A and TMT-B was comparable in patients and healthy subjects. Other studies that employed different measures such as the Wisconsin Card Sorting Test and the Stroop colour-word test reported impaired performance of depressed patients. 9, 48 The deficit in executive function does not seem to be related to current illness state, although it is possibly related to the level of difficulty of the measures employed.
Factors Predicting Cognitive Performance in MDD
Investigators have only sometimes examined the factors that predict performance of adult depressed patients on cognitive measures, and almost no study has had the power to examine more than a few factors in 1 analysis. Further, correlational analyses were frequently employed without examining the unique contribution of each factor to the cognitive domain of interest. However, of note, Butters et al 49 examined the determinants of cognitive performance in late-life depression. In our analyses, we first grouped our dependent variables into cognitive domains using principal components factor analysis. Subsequently regression analyses were computed to examine the contribution of several patient and illness factors to the performance of depressed patients on the cognitive constructs that were impaired. The duration of illness, number of hospitalizations, and the FSIQ made a significant and independent contribution to cognitive performance of depressed patients. Duration of depressive illness predicted performance of patients on verbal memory and speed of processing and number of hospitalizations predicted performance of patients on speed of processing; and FSIQ predicted performance of patients on verbal memory. Interestingly, a recent study suggested that lower cognitive ability may be a risk factor for depression. 50 Notably, severity of depressive symptoms as measured by the HDRS was not correlated with and did not contribute to performance of depressed patients on any domain. The effect of mood state has been the focus of many studies. Whether cognitive dysfunction in depression is a state deficit or a trait deficit has been questioned by several researchers, although it appears likely that the answer may be that it is both. That is, cognitive function in severely depressed patients may be worse, on average, than in patients with mild depression. When patients remit from an acute episode, cognitive dysfunction may still be detectable in a portion of patients, suggesting that there is a relatively stable change that is not simply a function of mood state. Some have suggested that the ongoing cognitive impairment is a function of subthreshold symptoms, but this has been inconsistently supported. It would not be surprising if patients who only experience relatively mild symptoms were least likely to experience the pathophysiological changes that may contribute to the ongoing dysfunction observed in some patients. The possibility of a correlation between symptom severity when ill and performance when recovered has not been examined, likely in part because of the complexity in determining how best to quantify severity of an episode over an entire episode. Another interesting finding is related to the effect of age at the time of assessment on performance of depressed patients. In our sample, age was correlated with speed of processing, as reported by others. 49 However, it did not independently contribute to the performance of patients after accounting for other factors. Age did not contribute to or correlate with performance of patients on verbal memory. Further, age of onset of depression, family history of mood disorder, comorbid anxiety, and history of alcohol abuse were not correlated with and did not contribute to patients' performance.
Studies have suggested that cognitive dysfunction is genetically determined in part by the polymorphisms in BDNF 51 and that variation in the BDNF gene predicts declarative memory performance. 52, 53 Moreover, a genomic locus encoding the kidney and brain protein gene is associated with memory performance in healthy subjects. 54 Whether the same applies to depression and mood disorders remains to be studied, although provocatively, variation at the same locus of the BDNF gene has been associated with several aspects of vulnerability to and recovery from depression. 55
Conclusion
Depression is not a homogenous syndrome, 56 it is a diverse clinical condition with a wide range of outcomes. Studies suggest that depression is associated with cognitive impairment; however, the profile of this impairment is controversial because studies have enrolled patients with diverse demographics and clinical characteristics, employed different neuropsychological measures, and used various statistical methodologies particularly to control for type I error.
The magnitude and profile of cognitive deficits in depressed patients may in part be attributed to the patient characteristics and illness factors. Premorbid IQ contributes significantly to cognitive performance of depressed patients, while clinical characteristics that are indicative of burden of illness also contribute to dysfunction. Future studies examining cognitive performance of patients with mood disorders should further examine the contribution of other important factors such as key genetic and biological markers of illness.
Résumé : Facteurs cliniques qui prédisent la fonction cognitive des patients souffrant de dépression majeure
Objectifs : Comparer le rendement des patients déprimés avec celui de sujets témoins en santé dans des domaines cognitifs distincts dérivés d'analyses factorielles, et examiner les facteurs qui peuvent influencer le rendement des patients déprimés dans des domaines cognitifs dans un vaste échantillon.
Méthodes : Nous avons comparé le rendement cognitif de 149 patients souffrant de dépression majeure avec celui de 104 sujets témoins en santé à l'aide de l'ANCOVA multivariée. Nous avons utilisé l'analyse factorielle en composantes principales pour grouper les variables cognitives en domaines cognitifs. Enfin, nous avons effectué une analyse de régression pour examiner la contribution des facteurs prédicteurs aux domaines cognitifs qui étaient déficients dans le groupe des patients déprimés.
Résultats : La mémoire verbale et la vitesse de traitement étaient déficientes chez les patients déprimés, comparativement aux sujets témoins en santé. Le QI des patients, la durée de la maladie dépressive, et le nombre d'hospitalisations contribuaient significativement au rendement des patients dans le domaine de la mémoire verbale et de la vitesse de traitement. La gravité des symptômes de l'humeur ne corrélait avec le rendement dans aucun domaine cognitif.
Conclusions :
Comprendre les facteurs qui prédisent le rendement cognitif des patients souffrant de dépression peut donner un aperçu des processus par lesquels la dépression entraîne une dysfonction cognitive. Notre étude a démontré que le QI pré-morbide et les facteurs liés au fardeau de la maladie sont de puissants prédicteurs indépendants de la dysfonction cognitive chez les patients souffrant de dépression majeure.
